Policy & Regulation

Oncology drug approvals rise, with help from China

The Human Brain Project

WHO panel advises on governance of genome editing

A new paradigm for gene therapy

Addressing the challenges of gene therapy medicinal products

EU medicine approvals with public health impact

Drug development robust, despite the pandemic

Real world evidence is changing regulatory policy

Integrated product development for ATMPs

Establishing a new role for real world evidence